Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Clinical trial NCT06470243 · RECRUITING

Trial details

NCT number

NCT06470243

Sponsor

SWOG Cancer Research Network

Status

RECRUITING

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2024-11-27

Primary completion

2029-06-30

Enrollment

528

View on ClinicalTrials.gov